Boeing Co is a leading aerospace company that designs, manufactures, and sells airplanes, rotorcraft, rockets, satellites, and telecommunications equipment worldwide. The company serves a wide range of customers, including commercial airlines, government agencies, and defense organizations, providing innovative solutions for air travel and space exploration. Through its diverse portfolio, Boeing is involved in both commercial and military aircraft production, as well as technologies related to space and satellite operations, aiming to enhance global connectivity and advance aerospace technology. Additionally, Boeing engages in maintenance, repair, and logistics services to support its products throughout their lifecycle. Read More
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Boeing Company (“Boeing” or the “Company”) (NYSE: BA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK CITY, NY / ACCESS Newswire / June 20, 2025 / Pomerantz LLP is investigating claims on behalf of investors of The Boeing Company ("Boeing" or the "Company") (NYSE:BA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against The Boeing Company (“Boeing” or the “Company”) (NYSE: BA) on behalf of Boeing stockholders. Our investigation concerns whether Boeing has violated the federal securities laws and/or engaged in other unlawful business practices.
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Boeing Company (“Boeing” or the “Company”) (NYSE: BA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The agreement aims to support future studies investigating the combination of MAIA’s Ateganosine and Roche’s checkpoint inhibitor, Atezolizumab, for safe and effective cancer treatments.
The company said its seven factories will span three manufacturing mega-sites and manufacture “hundreds of millions” of U.S.-made chips daily, while creating over 60,000 new U.S. jobs.
According to The Wall Street Journal report, there are only a limited number of scenarios where the emergency system, known as the ram air turbine (RAT), can kick in.
Boeing’s first quarter results drew a strong positive market response, with management attributing performance improvements to operational execution and progress in stabilizing its production system. CEO Kelly Ortberg highlighted reductions in traveled work and rework hours on the 737 line, as well as better-than-expected airplane deliveries, which reduced cash outflows. Ortberg noted, “Almost every customer I talk with reports an improvement to the quality of the airplane.” The company also emphasized that recent changes to its quality and safety processes are gaining traction, particularly in the commercial aircraft division. While defense segment margin improvement and a major contract win for the F-47 fighter were called out, management continued to acknowledge ongoing challenges in the China market due to tariffs.
